Medical Devices
-
Tandem’s Elizabeth Gasser on patch pump plans, Abbott partnership
The strategy and product exec said Tandem aims to give patients options and reach more people who haven’t yet used insulin pumps.
By Elise Reuter • June 25, 2025 -
Moon Surgical hires 3 executives for soft tissue robot expansion push
The challenger to Intuitive Surgical said its Maestro platform has aided in more than 1,600 surgeries to date, with the majority performed in the past year.
By Susan Kelly • June 25, 2025 -
Explore the Trendlineâž”
Sarah Silbiger via Getty ImagesTrendlineMedical device safety in spotlight after high profile recalls
From Philips’ massive recall of respiratory devices to ongoing health risks with breast implants, medical devices tied to patient harm have put a focus on product safety.
By MedTech Dive staff -
FDA stops Olympus devices from entering the US
The agency said it issued the import alerts because it “continues to have concerns related to outstanding Quality System regulation violations by Olympus.”
By Nick Paul Taylor • June 25, 2025 -
ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors
Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared updates on its implantable glucose sensors.
By Elise Reuter • June 24, 2025 -
GE Healthcare recalls Carestation devices over ventilation failure risk
The recall affects 15 Carestation models and more than 14,000 individual devices.
By Nick Paul Taylor • June 24, 2025 -
EU limits Chinese companies’ access to public medtech contracts
The move to block Chinese medical device companies from bidding on EU government contracts is intended to defend EU-based businesses from unfair treatment in China, the European Commission said.
By Susan Kelly • June 23, 2025 -
MedTech Europe urges EU to exclude devices, diagnostics from trade war
MedTech Europe said the EU’s list of products it could target in retaliation for U.S. actions “includes over 800 trade codes related to medical technologies.”
By Nick Paul Taylor • June 23, 2025 -
Illumina to buy SomaLogic for up to $425M
Illumina said adding SomaLogic would support the company’s multiomics strategy and strengthen the value of its NovaSeq X products.
By Susan Kelly • June 23, 2025 -
Insulet’s Eric Benjamin shares update on automated insulin delivery system
The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since receiving an expanded indication, and shared an update on plans for a closed-loop system.
By Elise Reuter • June 23, 2025 -
Rise in VC activity tees up ‘strong year’ for medtech funding: PitchBook
Improvements in VC funding contrasted with M&A activity, which has fallen short of the level PitchBook predicted under the Trump administration.
By Nick Paul Taylor • June 20, 2025 -
5 things to watch at the ADA’s Scientific Sessions
The American Diabetes Association’s annual conference kicks off amid a dynamic year for diabetes tech, as access improves for people with Type 2 diabetes and companies debut new devices.
By Elise Reuter • June 20, 2025 -
Virtual Incision appoints former Intuitive exec as CEO
Virtual Incision has selected Jim Alecxih as its new CEO as the company prepares a series of FDA submissions for its next robotic surgery system, called M2.
By Susan Kelly • June 20, 2025 -
Medtronic training pact includes Hugo robot, cardiac ablation tech
The medical device maker is partnering with IRCAD, a surgical education and research institute, to train medical personnel in cardiovascular, neuroscience and minimally invasive specialties.
By Susan Kelly • June 18, 2025 -
Q’Apel recalls clot removal device in response to FDA warning letter
Rather than pursuing a new regulatory pathway, Q'Apel said it is discontinuing the recalled system “as part of its strategic shift toward newer technologies.”
By Nick Paul Taylor • June 18, 2025 -
Dexcom recalls more than 700,000 CGM receivers for lack of audible alarm
Severe adverse events, including seizure and loss of consciousness, were potentially linked to the issue, based on 56 reports Dexcom received.
By Elise Reuter • Updated June 24, 2025 -
Anne Wojcicki wins bid to buy back 23andMe for $305M
A nonprofit led by the co-founder and former CEO of 23andMe outbid competitors for nearly all of the company’s assets.
By Elise Reuter • June 17, 2025 -
SS Innovations’ robot used in its first cardiac surgery in Americas
The robot maker, which is expanding globally, believes it can stand out in competition with market leader Intuitive Surgical with a technologically advanced system that is affordable and accessible.
By Susan Kelly • June 17, 2025 -
Zyno recalls infusion pumps over unvalidated software
Customers have been asked to stop using the pumps and wait for someone to contact them about exchanging devices.
By Nick Paul Taylor • June 17, 2025 -
Centerline recalls guidewire over risk of coating being left in patients
Coating for the guidewires could come off and get left in patients, which could result in extended or additional procedures. No serious injuries or deaths have been tied to the recall.
By Nick Paul Taylor • June 16, 2025 -
Q&A
Abbott’s new diabetes leader on latest sensors, partnerships and Type 2 coverage
Ahead of the American Diabetes Association’s Scientific Sessions, Chris Scoggins said Abbott’s ambition is to be the most broadly connected diabetes tech company.
By Elise Reuter • June 12, 2025 -
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
The recall comes more than one year after Medtronic announced it would exit the ventilator market.
By Nick Paul Taylor • June 12, 2025 -
Trump says tariff deal with China is ‘done’
The proposed agreement, pending approval from both countries, sets 55% tariffs on imports from China and a 10% rate on U.S. products, the president said Wednesday.
By Philip Neuffer • June 11, 2025 -
FDA schedules first public MDUFA VI meeting ahead of negotiations
Officials want to know what current features should be reduced or stopped to “ensure the continued efficiency and effectiveness of the medical device review process.”
By Nick Paul Taylor • June 11, 2025 -
Tandem, Abbott team on insulin delivery with glucose-ketone sensor
Tandem will integrate its insulin delivery systems with a new dual glucose-ketone sensor being developed by Abbott.
By Elise Reuter • June 10, 2025 -
Elekta appoints Jakob Just-Bomholt as CEO
The company cited Just-Bomholt’s strategic leadership, international experience and ability to drive profitable growth and global expansion as evidence he is the right person for the job.
By Nick Paul Taylor • June 10, 2025